Meta-Analysis of the Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Patients With Polycystic Ovary Syndrome

Am J Ther. 2021 Jul 1;29(2):e245-e248. doi: 10.1097/MJT.0000000000001418.

Authors

Lei Li¹, Shu-Fang Wang², Meng-Ru Du¹, Sheng Jiang¹

Affiliations

¹ Department of Endocrinology, the First Affiliated Hospital of Xinjiang Medical University, State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Urumqi, China.
² Department of Endocrinology, Cao County People's Hospital of Shandong Province, Heze, China.

PMID: 34224428
DOI: 10.1097/MJT.0000000000001418

No abstract available

Publication types

Meta-Analysis

MeSH terms

Diabetes Mellitus, Type 2* / drug therapy
Female
Glucagon-Like Peptide-1 Receptor / agonists
Humans
Hypoglycemic Agents / adverse effects
Polycystic Ovary Syndrome* / drug therapy

Substances

Glucagon-Like Peptide-1 Receptor
Hypoglycemic Agents